Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis
Clinical trial NCT05359315 · UNKNOWN
Trial details
- NCT number
- NCT05359315
- Sponsor
- SPP Pharmaclon Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-15
- Primary completion
- 2022-08-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.